LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT)
Phase of Trial: Phase II
Latest Information Update: 30 May 2018
At a glance
- Drugs Ulipristal (Primary)
- Indications Charcot-Marie-Tooth disease
- Focus Pharmacodynamics
- Acronyms UPACOMT
- 24 May 2018 Status changed from recruiting to discontinued.
- 15 May 2017 Status changed from not yet recruiting to recruiting.
- 29 Oct 2015 New trial record